As shown in Figure 6A, the highest mutation frequency of OSBPL3 (>6%) appears for patients with uterine corpus endometrial carcinoma and the amplification (an alteration frequency of ∼5%) appears for the esophageal adenocarcinoma. The gene discussed is OSBPL3; the disease is uterine corpus endometrial carcinoma.